This section provides various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Current Ratio, Quick Ratio, Cash Ratio, Net Profit Margin, P/E Ratio for ANIK as of 2025-12-31.
| Financial Ratios | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-09-30 |
|---|---|---|---|---|
| P/E Ratio | -13.444 | -10.511 | -2.279 | -5.949 |
| Net Profit Margin | -4.703 | -9.034 | -9.292 | -75.357 |
| Cash Ratio | 262.374 | 303.788 | 330.62 | - |
| Quick Ratio | 386.028 | 446.886 | 512.375 | - |
| Current Ratio | 471.782 | 532.191 | 617.605 | - |
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)